


Ask a doctor about a prescription for ARICEPT 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Aricept 5 mg Film-Coated Tablets
Donepezil Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.Keep this leaflet. You may need to read it again.
Contents of the pack and other information
Aricept belongs to a group of medicines called acetylcholinesterase inhibitors. Donepezil hydrochloride increases the levels in the brain of a substance related to memory (acetylcholine), by reducing the speed of breakdown of this substance.
It is used for the treatment of the symptoms of Alzheimer's disease of mild to moderate severity. The symptoms include increasing memory loss, confusion, and changes in behavior.
Do not take Aricept:
Warnings and precautions
Consult your doctor before starting to take Aricept if you have or have had:
You should avoid taking Aricept with other acetylcholinesterase inhibitors and other agonists or antagonists of the cholinergic system.
Other medicines and Aricept
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, especially if you are taking any of the following medicines:
In the event of surgical intervention with general anesthesia, you should inform your doctor that you are taking Aricept, as this may affect the amount of anesthetic needed.
Aricept can be used in patients with mild to moderate kidney or liver disease. Inform your doctor before starting treatment if you have kidney or liver problems. Patients with severe liver disease should not take Aricept.
Taking Aricept with food, drinks, and alcohol
This medicine should be taken with a little water.
Aricept should not be taken with alcohol, as alcohol may alter the effect of this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take Aricept if you are breastfeeding.
Driving and using machines
Your illness may affect your ability to drive or use machines, and you should not carry out these activities unless your doctor tells you it is safe to do so. Aricept may cause fatigue, dizziness, somnolence, and muscle cramps, mainly at the start of treatment or when increasing the dose. If you experience these effects, you should not drive or use machines.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
Aricept is administered orally.
Treatment with Aricept starts with one 5 mg tablet, taken once daily with a little water, at night, immediately before bedtime. After one month of treatment, your doctor may tell you to increase the dose to 10 mg, once daily, at night. The maximum recommended dose is 10 mg per day.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take Aricept in the morning.
If you have mild to moderate liver or kidney disease, you can take Aricept. Inform your doctor before starting treatment if you have liver or kidney problems. Patients with severe liver disease should not take Aricept.
Use in children
Aricept is not recommended for use in children.
If you take more Aricept than you should
If you have taken more Aricept than you should, contact your doctor, pharmacist, or call the Toxicology Information Service, telephone: 91 562 04 20, stating the medicine and the amount used.
Symptoms of overdose may include nausea (feeling sick), vomiting (being sick), drooling, sweating, decreased heart rate, low blood pressure (dizziness or fainting when standing up), breathing problems, loss of consciousness, and seizures.
If you forget to take Aricept
Do not take a double dose to make up for forgotten doses.
If you stop taking Aricept
Do not stop taking Aricept unless your doctor tells you to. If you stop taking Aricept, the benefits of the treatment will gradually disappear.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Aricept can cause side effects, although not everybody gets them.
The following side effects have been reported by people taking Aricept.
Contact your doctor if you have any of these side effects during treatment with Aricept.
Serious side effects:
You should tell your doctor immediately if you notice any of the following serious side effects, as you may need urgent medical treatment.
The estimated frequency of occurrence of side effects is as follows:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 10,000 people
Frequency not known (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Monitoring System for Human Use, Website: www.notificaRAM.es
Keep this medicine out of the sight and reach of children.
Store below 30°C.
Do not use Aricept after the expiry date stated on the carton. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Aricept 5 mg film-coated tablets
Appearance of the product and pack contents
Aricept 5 mg film-coated tablets are available in a pack size of 28 tablets, in a blister pack formed by PVC with an aluminum foil on the back.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
Manufacturer:
Fareva Amboise
Zone Industrielle
29 route des Industries
37530 Pocé-sur-Cisse
France
or
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:
Eisai Farmacéutica, S.A.
Parque Empresarial Cristalia.
Calle Via de los Poblados 3, Edf. 7/8
4th floor
28033 Madrid
Tel: + (34) 91 455 94 55
Date of last revision of this leaflet: December 2022
"Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/"
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ARICEPT 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.